• The UPCDC Team presented several posters at the 252nd ACS National Meeting in Philadelphia:

• The University of Pittsburgh Chemical Diversity Center (UPCDC), a proud member of the Chemical Biology Consortium since 2009, has been tapped in 2016 to continue its participation in the national network of scientists on the leading edge of drug discovery and development in the fight against cancer. From the Kick-Off meeting in Bethesda in June 2016:

• Collaborative academic drug discovery yields first small molecule inhibitor - AAA ATPase p97 cryo-EM structure.

Reference: Banerjee et al., 2016. 2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition. Science. Online January 28, 2016.